Literature DB >> 17729034

FcgammaRIIB as a modulator of autoimmune disease susceptibility.

Tatyana Tarasenko1, Jonathan A Dean, Silvia Bolland.   

Abstract

Antibodies are secreted to recognize and in some cases directly neutralize pathogens. Another important means by which they are essential components of the immune system is through binding to Fc receptors. Effector responses triggered by antibody binding of Fc receptors affect a host of important cellular responses such as phagocytosis, inflammatory cytokine release, antigen presentation, and regulation of humoral responses. A crucial check on this antibody-mediated signal is through the inhibitory receptor, FcgammaRIIB. In this review we discuss how dysregulation of FcgammaRIIB can result in a lowered threshold for autoimmunity in mice and humans. We close with a discussion of the potential for applying these findings to immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17729034     DOI: 10.1080/08916930701464665

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  20 in total

Review 1.  Historical overview of immunological tolerance.

Authors:  Ronald H Schwartz
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

Review 2.  B cells as therapeutic targets in SLE.

Authors:  Iñaki Sanz; F Eun-Hyung Lee
Journal:  Nat Rev Rheumatol       Date:  2010-06       Impact factor: 20.543

3.  Making autoantibodies safe.

Authors:  Christopher N Scanlan; Dennis R Burton; Raymond A Dwek
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-14       Impact factor: 11.205

Review 4.  Involvement of Fc receptors in disorders of the central nervous system.

Authors:  Eitan Okun; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2009-10-21       Impact factor: 3.843

5.  The presence of FCGR2B promoter or transmembrane region variant alleles leads to reduced serum IL-6 levels in rheumatoid arthritis.

Authors:  Stefanie Meister; Robby Engelmann; Christian Kneitz; Brigitte Müller-Hilke
Journal:  Rheumatol Int       Date:  2015-01-29       Impact factor: 2.631

6.  Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses.

Authors:  Xinrui Li; Jianming Wu; Travis Ptacek; David T Redden; Elizabeth E Brown; Graciela S Alarcón; Rosalind Ramsey-Goldman; Michelle A Petri; John D Reveille; Richard A Kaslow; Robert P Kimberly; Jeffrey C Edberg
Journal:  Sci Transl Med       Date:  2013-12-18       Impact factor: 17.956

Review 7.  PI3Ks in lymphocyte signaling and development.

Authors:  Klaus Okkenhaug; David A Fruman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

8.  Generation of gene-engineered chimeric DNA molecules for specific therapy of autoimmune diseases.

Authors:  Vera Gesheva; Zsuzsanna Szekeres; Nikolina Mihaylova; Iliyana Dimitrova; Maria Nikolova; Anna Erdei; Jozsef Prechl; Andrey Tchorbanov
Journal:  Hum Gene Ther Methods       Date:  2012-11-23       Impact factor: 2.396

9.  Application of knockout mouse models to investigate the influence of FcγR on the pharmacokinetics and anti-platelet effects of MWReg30, a monoclonal anti-GPIIb antibody.

Authors:  Lubna Abuqayyas; Xiaoyan Zhang; Joseph P Balthasar
Journal:  Int J Pharm       Date:  2013-01-28       Impact factor: 5.875

10.  Selective regulation of autoreactive B cells by FcgammaRIIB.

Authors:  Jeganathan Venkatesh; Daisuke Kawabata; Sunjung Kim; Xiaonan Xu; Prameladevi Chinnasamy; Elahna Paul; Betty Diamond; Christine M Grimaldi
Journal:  J Autoimmun       Date:  2009-03-26       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.